DWG-1267

N/A

Report date: 2025/01/26 17:33:22
NME

Base Information

Drug NameDWG-1267
Drug Alias Nameindoleamine 2,3-dioxygenase 1 inhibitors (Krembil Research Institute/University of Toronto)DWG-1267
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesToronto Western Hospital
China Registration ClassN/A

Develop Information

Active CompaniesToronto Western HospitalUniversity of Toronto
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A